Ross A Miller MD

Husband, father, and an inquisitive surgical and cytopathologist - Tweets do not equal medical advise.

[Ross A Miller MD @rmille01]

@LinaHidalgoTX Lina for President!

[Ross A Miller MD @rmille01]

#CBCIII Superb conference, great speakers, great venue!
Look forward to the next one.@PhilipTCagle @Sinchita_Roy @barr1_roberto @evemariecrane @TimAllenMDJD

[Ross A Miller MD @rmille01]

Truer words have never been said.... Dr. Alain Borczuk on PDL1 as a biomarker. #CBCIII @Sinchita_Roy @PhilipTCagle @TimAllenMDJD @evemariecrane

[Christina Ventura @chrisventura04]

Dr. Alan Borczuk explains PD-L1 biomarker testing challenges. #CBCIII

[Genevieve Crane, MD, PhD @evemariecrane]

Cell free applications: early detection not yet here and may require ~100 cc of blood; assess significance of radiographic incidentalomas; late stage disease assessment of tissue of origin #CBCIII Dr. Iafrate

[Christina Ventura @chrisventura04]

Dr. Neal Lindeman of @BrighamWomens discussing the updated Lung Biomarkers Guideline @Pathologists @AMPath @IASLC @PhilipTCagle @EricBernicker #CBCIII Biomarkers Conference @MethodistHosp

[Genevieve Crane, MD, PhD @evemariecrane]

Sequencing challenges for cell free DNA— much lower likely tumor fraction, higher sensitivity of 0.1% required. MGH panel focuses on hotspots, significant validation challenges. Dr. Iafrate #CBCIII

[Genevieve Crane, MD, PhD @evemariecrane]

POLE ultramutated, a newly identified subset of endometrial cancer discovered using molecular not histologic markers. Tons of mutations, including some MSI unstable, better prognosis #CBCIII Dr Teri Longacre

[Eric Bernicker MD FASCO @EricBernicker]

Dara Aisner discusses the financial and regulatory issues behind molecular testing -- I think many oncologists not aware of many of the significant issues that will determine the accessibility of genomic info that we use to treat patients #CBCIII

[Adam L. Booth, MD @ALBoothMD]

Dr. Teri Longacre @StanfordPath with updates on endometrial cancer biomarker testing, highlighting MMR IHC interpretation problems and a reminder to always have an internal control #CBCIII

[Genevieve Crane, MD, PhD @evemariecrane]

Molecular subtypes of gastro-esophageal cancer correlate with anatomic location. Of these, EBV+ has best prognosis — Dr. Kay Washington #CBCIII

[Christina Ventura @chrisventura04]

Dr. Richard Brown discusses how clinical practice guidelines help with building consensus and standardization #CBCIII

[Nicole Thomas @nicnac0]

Personal tweet: my shoutout from Dr. Mary Schwartz means a lot. I put in a LOT of work to help experts develop our guidelines and to be acknowledged at meeting like #CBCIII is an honor. I get to work with best around the world!

[Genevieve Crane, MD, PhD @evemariecrane]

Type of paraffin, choice of glass slides and other factors can influence your DNA yield #CBCIII #whypathologistsmatter @Sinchita_Roy

[Ross A Miller MD @rmille01]

Great things happening at #CBCIII, my personal favorite quote of the day: “#1 side effect of HPV vaccination is pain at injection site, and that will go away, get your kids vaccinated” - the great Dr Mary Schwartz. @PhilipTCagle @evemariecrane @Sinchita_Roy @EricBernicker

[Genevieve Crane, MD, PhD @evemariecrane]

What are the controversies in head and neck cancer HPV guidelines? Dr. Mary Schwartz discusses development of @Pathologists guidelines now published in @ArchivesPath and endorsed by @ASCO #CBCIII

[Ross A Miller MD @rmille01]

MMR interp problems - good things to remember #CBCIII @PhilipTCagle @evemariecrane @

[Adam L. Booth, MD @ALBoothMD]

Be careful not to overstate the likelihood of Lynch Syndrome @RhondaYantiss #CBCIII #gipath

[Jianping Zhao, MD.PhD @JPZhaoMD]

Dr. Richard Brown from Memorial Hermann shares their experiences on, "Biomarker testing in community practice"
#CBClll @ALBoothMD @PhilipTCagle @Sinchita_Roy @evemariecrane

[Ross A Miller MD @rmille01]

Late in the afternoon and still a full house at #CBCIII - a true testament to the quality of presentations @PhilipTCagle @evemariecrane